Achaogen's Series C Round

Achaogen raised a round of funding on April 08, 2010.

Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular. Achaogen focuses on high …

Articles about Achaogen's Series C Round: